Additionally, the frequency of PD-1+/CD8+ T cells was found to be higher in bone marrow samples obtained from patients with multiply relapsed AML compared to those with first relapsed or newly-diagnosed AML (25). This evidence concerns the gene CD8A and acute myeloid leukemia.